Your browser doesn't support javascript.
loading
CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer.
Bugide, Suresh; Edwards, Yvonne J K; Gupta, Romi; Green, Michael R; Wajapeyee, Narendra.
Afiliación
  • Bugide S; Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35222.
  • Edwards YJK; Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35222.
  • Gupta R; Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35222.
  • Green MR; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35222.
  • Wajapeyee N; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605.
Proc Natl Acad Sci U S A ; 120(4): e2218118120, 2023 01 24.
Article en En | MEDLINE | ID: mdl-36652476
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos